Dario Scimeca, an officer of Precision Biosciences Inc, filed a Form 144 notice on November 10, 2026, proposing the sale of 2,821 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ.
Key Highlights
- Proposed seller: Dario Scimeca, identified in the filing as an officer of Precision Biosciences Inc.
- Shares proposed for sale: 2,821 shares of common stock, with an aggregate market value of $27,516.91 according to the filing.
- Shares outstanding: The filing reports 27,935,719 shares of common stock outstanding.
- Approximate sale date: November 10, 2026, through Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.
- Rule 10b5-1 plan: The filing indicates a plan adoption or instruction date of September 26, 2025.
- Acquisition history: The shares were acquired through multiple ESPP purchases and restricted stock vestings between February 28, 2020, and June 7, 2024.
- Prior three-month sales: The filing reports nothing to report under securities sold during the past three months.
Scimeca Form 144 Filing: Acquisition History and Proposed Sale Details
According to the filing, Dario Scimeca, an officer of Precision Biosciences Inc (NASDAQ:DTIL), submitted a Form 144 notice proposing to sell 2,821 shares of the company's common stock. The aggregate market value of the proposed sale is listed as $27,516.91. The notice names Fidelity Brokerage Services LLC as the executing broker and identifies NASDAQ as the exchange on which the sale is to occur. The filing states that the sale is being made in reliance on a Rule 10b5-1 plan or instruction adopted on September 26, 2025.
The filing details the acquisition history of the securities proposed for sale. The shares were accumulated through a combination of Employee Stock Purchase Plan (ESPP) purchases and restricted stock vestings. ESPP purchases occurred on February 28, 2020 (69 shares), August 31, 2020 (105 shares), February 26, 2021 (92 shares), August 31, 2021 (18 shares), February 28, 2022 (68 shares), and February 28, 2023 (72 shares), all paid in cash and acquired from the issuer. Restricted stock vestings occurred on June 7, 2022 (731 shares), March 3, 2023 (513 shares), June 7, 2023 (614 shares), November 2, 2023 (331 shares), and June 7, 2024 (208 shares), each listed as compensation from the issuer.
The filing reports no securities sold by Scimeca during the three months preceding this notice. The notice was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Dario J. Scimeca. The issuer's address is listed as 302 East Pettigrew Street, Suite A-100, Durham, North Carolina 27701.
What Was Disclosed
Precision Biosciences officer Dario Scimeca filed a Form 144 notice proposing to sell 2,821 shares of common stock valued at $27,516.91, with an approximate sale date of November 10, 2026, under a Rule 10b5-1 plan adopted September 26, 2025.






Please wait processing your request...